1Tyldesley S,Boyd C,Schiclzek,et al.Estimating the need for radiotherapy for lung cancer:an evidence-based,epidemiologic approach[J].Int J Radiat Oncol Biol Phys,2001,49(4):973-985.
2Mac Manus MP.Role of PET in assessing response to radical chemoradiation[J].Lung Cancer,2003,41(Suppl 3):65.
3Mah K,Caldwell CB,Ung YC,et al.The impact of18 FDG PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma:a prospective study[J].Int J Radiat Oncol Biol Phys,2002,52(2):339-350.
4Erdi YE,Rosenzweig K,Erdi AK,et al.Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)[J].Radiother Oncol,2002,62(1):51-60.
5Fang CL,Komaki R,Allen P,et al.Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional versus three dimensional radiotherapy[J].Lung Cancer,2005,49(Suppl 2):S49(0-142).
7Yom S,Liao Z,Liu H,et al.Analysis of acute toxicity results of intensity modulated radiation therapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC)[J].Lung Cancer,2005,49(Suppl 2):S52(0-152).
8Chang JY,Liu HH,Komaki R.Intensity medulated radiation therapy and proton radiotherapy for non-small cell lung cancer[J].Curr Oncol Rep,2005,7(4):255-259.
9Grills IS,Yan D,Martinez AA,et al.Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer:a comparison of intensity-modulated radiation therapy (IMRT),3D conformal radiation,and elective nodal irradiation[J].Int J Radiat Oncol Biol Phys,2003,57(3):875-890.
10Liu HH,Wang X,Dong L,et al.Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2004,58(4):1268-1279.
